Summary:
- Researchers are conducting a clinical trial of a new hepatitis B vaccine in Guinea-Bissau, a small country in West Africa.
- The trial aims to determine the safety and effectiveness of the vaccine in preventing hepatitis B infections in children and adults.
- Hepatitis B is a serious liver disease that can lead to liver damage, liver cancer, and even death if left untreated. This trial could help improve access to the vaccine and reduce the burden of hepatitis B in Guinea-Bissau and other parts of the world.